Abstract:Naturally occurring lanthipeptides, peptides post-translationally modified by various enzymes, hold significant promise as antibiotics. Despite extensive biochemical and structural studies, the events preceding peptide modification remain poorly understood. Here, we identify a distinct subclass of lanthionine synthetase KC (LanKC) enzymes with distinct structural and functional characteristics. We show that PneKC, a member of this subclass, forms a dimer and possesses GTPase activity. Through three cryo-EM structures of PneKC, we illustrate different stages of peptide PneA binding, from initial recognition to full binding. Our structures show the kinase domain complexed with the PneA core peptide and GTPγS, a phosphate-bound lyase domain, and an unconventional cyclase domain. The leader peptide of PneA interact with a gate loop, transitioning from an extended to a helical conformation. We identify a dimerization hot spot and propose a "negative cooperativity" mechanism toggling the enzyme between tense and relaxed conformation. Additionally, we identify an important salt bridge in the cyclase domain, differing from those in in conventional cyclase domains. These residues are highly conserved in the LanKC subclass and are part of two signature motifs. These results unveil potential differences in lanthipeptide modification enzymes assembly and deepen our understanding of allostery in these multifunctional enzymes.

Using LanM Enzymes to Modify Glycagon‐Like Peptides 1 and 2 in E.coli

Investigation of Protein Post-Translational Modifications with Site-Specifically Incorporated Non-Canonical Amino Acids

Molecular design of peptide therapeutics via N-terminal modification

Enhanced Activity of Rhizomucor Miehei Lipase by Deglycosylation of Its Propeptide in Pichia Pastoris

Neoglycolipids for Prolonging the Effects of Peptides: Self-Assembling Glucagon-like Peptide 1 Analogues with Albumin Binding Properties and Potent in Vivo Efficacy

Selective Modification of Ribosomally Synthesized and Post‐Translationally Modified Peptides (RiPPs) through Diels–Alder Cycloadditions on Dehydroalanine Residues

Molecular Insights into Ago-Allosteric Modulation of the Human Glucagon-Like Peptide-1 Receptor

Peptide Stapling via Crosslinking Two Amines with a‐Ketoaldehydes through Diverse Modified Glyoxal‐Lysine Dimer Linkers

Functional expression of diverse post-translational peptide-modifying enzymes in Escherichia coli under uniform expression and purification conditions

Development of Selective Nanomolar Cyclic Peptide Ligands as GBA1 Enzyme Stabilisers

Recombinant Expression and Stapling of a Novel Long-Acting GLP-1R Peptide Agonist

Identification of the effect of N-glycan modification and its sialylation on proteolytic stability and glucose-stabilizing activity of glucagon-like peptide 1 by site-directed enzymatic glycosylation

Exploiting Complex-Type N-Glycan to Improve the in Vivo Stability of Bioactive Peptides

Recent Developments in Therapeutic Peptides for the Glucagon-like Peptide 1 and 2 Receptors

Chemical modification of proteins by insertion of synthetic peptides using tandem protein trans-splicing

Oligomerization, albumin binding and catabolism of therapeutic peptides in the subcutaneous compartment: An investigation on lipidated GLP-1 analogs

Protection-Free Site-Directed Peptide or Protein S -Glycosylation and Its Application in the Glycosylation of Glucagon-like Peptide 1

Mechanistic insights into lanthipeptide modification by a distinct subclass of LanKC enzyme that forms dimers

Rapid Screening of Lanthipeptide Analogs Via In-Colony Removal of Leader Peptides in Escherichia Coli

Repurposing a plant peptide cyclase for targeted lysine acylation

Peptide Modifications: Versatile Tools in Peptide and Natural Product Syntheses